EN DE
STOCK COMPARISON

GKHT Medical Technology Co. Ltd. A vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how GKHT Medical Technology Co. Ltd. A (301370) and Abbott Laboratories (ABT) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: GKHT Medical Technology Co. Ltd. A trades at ¥8.78 versus a fair value of ¥3.53 (-60%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).
GKHT Medical Technology Co. Ltd. A
301370.SHE · CNY · Health Care
-60%
upside to fair value
overvalued
Price¥8.78
Fair Value¥3.53
Quality49/100
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$108
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

GKHT Medical Technology Co. Ltd. AAbbott Laboratories
Valuation
55.5×P/E (TTM)27.7×
0.61×P/S (TTM)3.89×
1.67×P/B3.36×
21.9×EV/EBITDA15.1×
PEG1.47×
Profitability
1%Net margin14%
1%Operating margin13%
3%Return on equity12%
1%Return on assets6%
Growth
-10%Revenue growth (YoY)8%
3.2%Avg. growth/yr (3Y)0.5%
Avg. growth/yr (5Y)5.1%
Balance & size
0.04×Debt / equity0.19×
$620MMarket cap$175B
mixedGrowth qualityhealthy

Abbott Laboratories leads: 4 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

GKHT Medical Technology Co. Ltd. Aof which business quality 52 · market factors 34 Abbott Laboratoriesof which business quality 66 · market factors 51
ProfitabilityMargins and returns on capital today
33
50
Quality GrowthAre margins and returns improving?
34
47
CashflowEarnings quality: real cash, not paper profit
72
71
Fin. StrengthBalance sheet, leverage, solvency risk
53
80
InvestmentDisciplined investing over empire-building
67
65
Low VolatilityCalm price path (market factor)
87
83
MomentumPrice trend over the last 3–12 months (market factor)
14
40
52W MomentumDistance to the 52-week high (market factor)
8
33
Net IssuanceBuybacks instead of dilution
52
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

GKHT Medical Technology Co. Ltd. A

DCF Models¥11.93
Earnings-Based¥3.22
Multiples¥5.19
Asset-Based¥3.57
Growth DCF¥15.01
Economic Profit¥4.34
Growth Earnings¥2.41

11 of 22 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

GKHT Medical Technology Co. Ltd. A
Bear ¥2.39Fair Value ¥3.53Bull ¥3.98
¥8.78 = current price (white tick)
Abbott Laboratories
Bear $51.84Fair Value $74.79Bull $94.43
$108 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

GKHT Medical Technology Co. Ltd. A · Health Care

Quality score49 · below median
Fair value upside-60% · below median

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-31% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: GKHT Medical Technology Co. Ltd. A trades at ¥8.78 versus a fair value of ¥3.53 (-60%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.